BL-M14D1 / Biokin Pharma - LARVOL DELTA

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: SystImmune Inc. | Not yet recruiting ➔ Recruiting | Initiation date: Sep 2025 ➔ Apr 2025

Enrollment open • Trial initiation date • Endocrine Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Lung Cancer • Merkel Cell Carcinoma • Neuroendocrine Tumor • Oncology • Prostate Cancer • Skin Cancer • Small Cell Lung Cancer • Solid Tumor • DLL3

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors (clinicaltrials.gov) - P1 | N=120 | Not yet recruiting | Sponsor: SystImmune Inc.

New P1 trial • Endocrine Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Lung Cancer • Merkel Cell Carcinoma • Neuroendocrine Tumor • Oncology • Prostate Cancer • Skin Cancer • Small Cell Lung Cancer • Solid Tumor • DLL3

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors (clinicaltrials.gov) - P1 | N=22 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Metastases • Endocrine Cancer • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors (clinicaltrials.gov) - P1 | N=22 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

Metastases • New P1 trial • Endocrine Cancer • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor